TP53 and breast cancer: In contrast, both p53 and p21 were significantly (P = 0.044, P = 2.8 × 10−6) higher in the OC users of the BC patients by 17.2% and 51.6% as compared to their respective non-OC users, with no significant difference in telomerase level.